United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-545_4c4c0bb8-ab70-3f03-e063-6294a90af0b9
- Product NDC
- 72189-545
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Direct_Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240409
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET, FILM COATED in 1 BOTTLE (72189-545-15) · 72189-545-15
- 21 TABLET, FILM COATED in 1 BOTTLE (72189-545-21) · 72189-545-21
- 30 TABLET, FILM COATED in 1 BOTTLE (72189-545-30) · 72189-545-30
- 60 TABLET, FILM COATED in 1 BOTTLE (72189-545-60) · 72189-545-60
- 90 TABLET, FILM COATED in 1 BOTTLE (72189-545-90) · 72189-545-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →